Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

Meet MTRC at the ISPOR meeting in Barcelona, 18-20 of November 2024

The MTRC team, including Director Oleg Borisenko and Reimbursement Leads, will be attending the ISPOR meeting in Barcelona on 18-20 November 2024. 

Visit us at booth #829 to discuss your needs in European market access, health economics, and evidence synthesis for medical technologies. 

You can also arrange a meeting via email info@mtrconsult.com 

Tags
Services of MTRC

The latest related news

01
Nov 2024

Typical profile of the MTRC customers

We are excited to share a detailed overview of the typical clients that MTRC frequently works with. 70% have Health Economics and Market Access (HEMA) responsibilities. 60% have global and 40% - EMEA responsibilities. 50% hold director and 33% - manager positions. 71% are located in Europe and 22% - in the US. 74% work for corporations. Read further details in the post.
Read more
31
Oct 2024

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support. From the week of November 4th, we are planning to work on 14 projects. Review the complete list of planned activities in this post.
Read more
21
Oct 2024

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support. From the week of October 21st, we are planning to work on 16 projects. Review the complete list of planned activities in this post.
Read more
18
Oct 2024

Health economists from MTRC co-authored study presented at the 34th Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

Oleg Borisenko, Andrey Maslov and Agni Baka co-authored research titled "Utility of MpMRI and phi in detection of prostate cancer in Italy: a decision analytic modeling" presented on 3-5th of October 2024, in Bologna, Italy. The analysis aimed at the evaluation of clinical and cost consequences of different diagnostic options for prostate cancer in Italy. Read the abstract of the research here.
Read more
04
Oct 2024

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support. From the week of October 7th, we are planning to work on 16 projects. Review the complete list of planned activities in this post.
Read more